Article Details

'Buy' on Cipla; firm likely to beat its cost-saving targets

Retrieved on: 2020-11-09 11:45:00

Tags for this article:

Click the tags to see associated articles and topics

'Buy' on Cipla; firm likely to beat its cost-saving targets. View article details on HISWAI:

Excerpt

<div>Cipla has added <b>Remdesivir</b> capacities with the help of third party manufacturers. Additonally, company is likely to beat its cost saving targets.</div>

Article found on:

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up